Trionfo Research, founded in the Asia-Pacific and driven by scientific expertise and operational excellence, is dedicated to improving the health of millions worldwide through clinical research supported by global service delivery, world-class scientific leadership, and specialized therapeutic knowledge.
Headquartered in Sydney, Australia, Trionfo Research is a leading contract research organization (CRO) with over 500 experienced professionals in 40 locations. We provide a comprehensive range of clinical trial services for pharmaceutical, medical device, and diagnostic companies, covering all trial phases, from registration to post-marketing trials. Our approach combines scientific and clinical leadership with expert trial delivery, offering unique, world-class solutions.
Through our partnership with The George Institute for Global Health, a renowned leader in chronic disease research with a global network of experts, we engage operationally supported, internationally recognized scientific leadership and extensive investigator networks. Together, we deliver customizable, clinical trial excellence from trial design through all delivery aspects.
As clinical trial costs and complexities continue to increase, our multidisciplinary experts provide innovative solutions to access patient populations and reduce sponsor R&D costs. We ensure that our clinical trials have a positive impact on clinicians and patients while maintaining the highest scientific integrity.
The George Institute for Global Health was established in Australia in 1999 to address the growing burden of non-communicable diseases and injuries worldwide. Since its inception, it has expanded to operate in more than 50 countries with 600 employees across its global centers. The institute has secured nearly $750 million for global health research, with a focus on addressing the primary causes of death and disability worldwide. It is now recognized as one of the top ten research institutions globally for its scientific impact.
Trionfo Research has formed a strategic partnership with EPS International (EPSI) to deliver clinical trial services in the Asia-Pacific region, the world's most populous area, as well as globally for their respective clients. EPSI provides clinical trial services for Trionfo Research clients in Japan, while Trionfo Research caters to EPSI and its Japanese customers across Asia, the United States, and Europe. Together, both companies offer a seamless operating capability for clinical trials across the Asia-Pacific region, except for China, where they maintain independent operating presences.
Established in 1991 as a pioneering CRO, EPS Group has been a healthcare solution provider across various sectors, including pharmaceutical companies, medical device manufacturers, hospitals, clinics, and academia, offering development, marketing, sales, and consultation services across Asia, with a focus on China. EPSI's strength lies in its significant presence in Japan, supported by multiple overseas offices in Asia, offering clinical development support services and SMO services. The company is also actively creating new value in areas such as big data, AI, and regenerative medicine.
